Navigation Links
The Quantum Group of Companies Exhibits at Statewide Medical Conference
Date:6/24/2008

Announces Annual Shareholder Meeting

WELLINGTON, Fla., June 24 /PRNewswire-FirstCall/ -- The Quantum Group (Amex: QGP) (http://www.QuantumMD.com) has announced that The Quantum Group of Companies, namely Renaissance Health Systems, are exhibiting at the 2008 Florida Medical Association (FMA) Annual Expo.

The FMA represents more than 16,000 physicians in the state and has established this annual meeting to provide members with exposure to new products and services, access to continuing medical education courses and seminars as well as networking opportunities. The expo runs from July 31 - August 3, 2008, and is being held at the Rosen Shingle Creek Resort in Orlando, Florida.

Noel J. Guillama, President & CEO of Quantum commented, "We have participated in the FMA Annual Meeting and Expo for several years and based on our experiences have now decided to hold our annual shareholder meeting during this specific event for many reasons. The FMA provides for heightened visibility and awareness of our Company throughout the state. Further, the timing provides the opportunity for our affiliated providers, many of which are also our shareholders, to participate in our annual meeting; and perhaps most importantly, this setting offers a unique backdrop for our shareholders who come from outside of the healthcare industry to see first hand what we do and to meet many members of our talented team."

The annual shareholder meeting of The Quantum Group has been scheduled for August 1, 2008 at 9 a.m. EST. The meeting will be held in The Butler Room at Rosen Shingle Creek Resort located at 9939 Universal Blvd., Orlando, Florida. As of June 13, 2008 there are 8,88
'/>"/>

SOURCE The Quantum Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Gene silencer and quantum dots reduce protein production to a whisper
2. The Quantum Group Announces Second Quarter Financial Results for Fiscal Year 2008
3. Microwave synthesis connects with the (quantum) dots
4. The Quantum Group & IBM Sign Research Collaboration Agreement for the LA Grid University Consortium
5. The Quantum Group Completes Corporate Expansion Plan; Employee and Corporate Office Growth Leads the Way for Enhanced Innovation and Growth Through 2009
6. The Quantum Group Announces Web-Based Portal for Physicians
7. The Quantum Group Executes First Medicaid Service Contract with HMO
8. The Quantum Group CEO to Deliver Keynote Address at EDC Life Science Conference
9. The Quantum Group Files Four Additional Patents
10. The Quantum Group Announces Increased Patient Enrollment Following Medicare Advantage Open Enrollment Period
11. The Quantum Group Extends CEOs Employment Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... Cambridge have discovered that the loss of a key segment ... the first study to show that this kind of genetic ... Nature . , The study, led by Dr Sadaf ... from the Wellcome Trust Sanger Institute, looked at 300 children ... genome looking for types of mutation known as copy number ...
(Date:12/6/2009)... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... 2b 003-A1 study, known as the 003 trial, ... relapsed and refractory multiple myeloma patients. These data ... at the 51st annual meeting of the American ... in this trial is complete (n=269), and full ...
(Date:12/6/2009)... Disorders information and Treatment site www.sleeping-with-a-sleeping-disorder.com ... with herbal or natural sleep aids from around ... for a good cause. The submissions will be ... Aids ,Encyclopedia, by YOU, to be sold from ... will donate 100% of the proceeds ,from sales ...
(Date:12/5/2009)... 5 There have been significant scientific advances in ... to gain a better understanding of how certain diseases ... provide patients with the best care. Research presented today ... of Hematology explores optimal induction therapies for managing multiple ...
(Date:12/5/2009)... NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative ... Research presented today at the 51st Annual Meeting ... new treatment options and improved diagnostic methods for ... leukemia, infant acute lymphoblastic leukemia, and myelofibrosis that ...
Breaking Medicine News(10 mins):Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9
... Living TV (RLTV) and,Maryland Public Television (MPT) ... on the healthcare system in America to ... television markets through RLTV,s,original series, Healthcare ,08: ... public leaders present their position on the ...
... may help improve air quality and encourage youngsters to play ... children who live in neighborhoods with lots of trees have ... with fewer trees, a new study finds. , Researchers looked ... asthma-related hospital admissions for children up to age 15, in ...
... the Only Treatment Approved to Both Reduce Exacerbations ... ... 30 The,U.S. Food and Drug Administration today approved Advair ... powder),for the reduction of exacerbations in patients with chronic obstructive,pulmonary ...
... diagnosed with congestive heart failure who receive implantable cardioverter-defibrillators ... longer than those that do not, according to researchers ... Further, the health care costs associated with ICDs, while ... increase downstream health care costs in this population. The ...
... 80%; Gross Profit Improves ... 161%; Operating Loss Declines by 96%, ALISO VIEJO, ... premier anatomic pathology and molecular testing services,resource for pathologists, oncologists ... first quarter ended,March 31, 2008. Revenue from continuing operations was ...
... urge oxytocin use after delivery, re-evaluation of accepted birthing ... intensive educational program for physicians and midwives that stresses ... delivery resulted in significantly fewer cases of excessive bleeding, ... countries. , Oxytocin helps contract the uterus and stop ...
Other Medicine News:Health News:Retirement Living TV Partners with Maryland Public Television to Address the Issue of Healthcare in America Through Its Series Healthcare '08: Search for Solutions 2Health News:Retirement Living TV Partners with Maryland Public Television to Address the Issue of Healthcare in America Through Its Series Healthcare '08: Search for Solutions 3Health News:Tree-Lined Streets Associated With Lower Childhood Asthma Rates 2Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 2Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 3Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 4Health News:Penn study finds elderly heart patients with ICD devices live longer after heart failure 2Health News:Clarient Reports First Quarter 2008 2Health News:Clarient Reports First Quarter 2008 3Health News:Clarient Reports First Quarter 2008 4Health News:Clarient Reports First Quarter 2008 5Health News:Clarient Reports First Quarter 2008 6Health News:Clarient Reports First Quarter 2008 7Health News:Clarient Reports First Quarter 2008 8Health News:Staff Training Reduces Postpartum Bleeding, Episiotomies 2Health News:Staff Training Reduces Postpartum Bleeding, Episiotomies 3
(Date:12/3/2009)... MADISON, N.J., Dec. 3 A genetic variation that ... life-threatening blood disorder if exposed to certain pharmaceutical therapies ... at cancer diagnostics leader Quest Diagnostics (NYSE: ... of Hematology (ASH) Annual Meeting and Exposition, December 5-8, ...
(Date:12/3/2009)... DIEGO, Dec. 3 BioMed Realty Trust, Inc. (NYSE: ... a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ... and office space at The Landmark at Eastview campus in ... 2023. This lease of additional space was completed approximately two ...
(Date:12/3/2009)... California, December 3 , ... C Viral Replication, Thereby Significantly Reducing Hepatitis C,Virus in ... Virus , - SPC3649 Demonstrates ... Adverse Events in the Treated Animals - Signaling a ...
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5As Teens Plug In Parents Fret 59129 1As Teens Plug In Parents Fret 59129 2As Teens Plug In Parents Fret 59129 3Gross Germ Spreading Behaviors Remain the Norm Despite Flu Season Concerns 59124 1Gross Germ Spreading Behaviors Remain the Norm Despite Flu Season Concerns 59124 2Gross Germ Spreading Behaviors Remain the Norm Despite Flu Season Concerns 59124 3Electronic Payment Exchange Welcomes New Visa Best Practices for Data Field Encryption 59123 1Electronic Payment Exchange Welcomes New Visa Best Practices for Data Field Encryption 59123 2Electronic Payment Exchange Welcomes New Visa Best Practices for Data Field Encryption 59123 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: